Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amit Misra

Showing results (61-70 of 102) with videos related to

Pageof 11
Sort By:
International Journal for Parasitology. Drugs and Drug Resistance|May 17, 2016
Supplementation of host response by targeting nitric oxide to the macrophage cytosol is efficacious in the hamster model of visceral leishmaniasis and adds to efficacy of amphotericin BSanketkumar Pandya, Rahul Kumar Verma, Prashant Khare, et al.
Tuberculosis (Edinburgh, Scotland)|September 30, 2010
Inhaled drug therapy for treatment of tuberculosisAmit Misra, Anthony J Hickey, Carlo Rossi, et al.
Molecular Pharmaceutics|March 9, 2012
Partial biodistribution and pharmacokinetics of isoniazid and rifabutin following pulmonary delivery of inhalable microparticles to rhesus macaquesRahul Kumar Verma, Jatinder Kaur Mukker, Ravi Shankar Prasad Singh, et al.
Molecular Pharmaceutics|September 18, 2012
Inhalable microparticles containing nitric oxide donors: saying NO to intracellular Mycobacterium tuberculosisRahul K Verma, Amit K Singh, Mradul Mohan, et al.
Molecular Pharmaceutics|August 13, 2016
Intranasal Eutectic Powder of Zolmitriptan with Enhanced Bioavailability in the Rat BrainTabassum Khan, Rajeev Ranjan, Yeshwant Dogra, et al.
Indian Journal of Experimental Biology|July 29, 2009
Inhalable microparticles containing isoniazid and rifabutin target macrophages and 'stimulate the phagocyte' to achieve high efficacyAwadh Bihari Yadav, Rolee Sharma, Pavan Muttil, et al.
Molecular Pharmaceutics|July 28, 2016
Inhalable Particles for "Pincer Therapeutics" Targeting Nitazoxanide as Bactericidal and Host-Directed Agent to Macrophages in a Mouse Model of TuberculosisAnuradha Gupta, Jairam Meena, Deepak Sharma, et al.
Tuberculosis (Edinburgh, Scotland)|April 9, 2013
Inhalable microparticles of nitric oxide donors induce phagosome maturation and kill Mycobacterium tuberculosisRahul Kumar Verma, Atul Kumar Agrawal, Amit Kumar Singh, et al.
Journal of Basic Microbiology|March 29, 2024
Insights into the genomic features and lifestyle of B1 subcluster mycobacteriophagesRitam Das, Ritu Arora, Kanika Nadar, et al.
The Journal of Physical Chemistry. B|September 22, 2015
Fluid and Resistive Tethered Lipid Membranes on Nanoporous SubstratesGautam Gupta, Kyle Staggs, Aditya D Mohite, et al.
Pageof 11

Showing results (61-70 of 102) with videos related to

Sort By:
Pageof 11
International Journal for Parasitology. Drugs and Drug Resistance|May 17, 2016
Supplementation of host response by targeting nitric oxide to the macrophage cytosol is efficacious in the hamster model of visceral leishmaniasis and adds to efficacy of amphotericin BSanketkumar Pandya, Rahul Kumar Verma, Prashant Khare, et al.
Tuberculosis (Edinburgh, Scotland)|September 30, 2010
Inhaled drug therapy for treatment of tuberculosisAmit Misra, Anthony J Hickey, Carlo Rossi, et al.
Molecular Pharmaceutics|March 9, 2012
Partial biodistribution and pharmacokinetics of isoniazid and rifabutin following pulmonary delivery of inhalable microparticles to rhesus macaquesRahul Kumar Verma, Jatinder Kaur Mukker, Ravi Shankar Prasad Singh, et al.
Molecular Pharmaceutics|September 18, 2012
Inhalable microparticles containing nitric oxide donors: saying NO to intracellular Mycobacterium tuberculosisRahul K Verma, Amit K Singh, Mradul Mohan, et al.
Molecular Pharmaceutics|August 13, 2016
Intranasal Eutectic Powder of Zolmitriptan with Enhanced Bioavailability in the Rat BrainTabassum Khan, Rajeev Ranjan, Yeshwant Dogra, et al.
Indian Journal of Experimental Biology|July 29, 2009
Inhalable microparticles containing isoniazid and rifabutin target macrophages and 'stimulate the phagocyte' to achieve high efficacyAwadh Bihari Yadav, Rolee Sharma, Pavan Muttil, et al.
Molecular Pharmaceutics|July 28, 2016
Inhalable Particles for "Pincer Therapeutics" Targeting Nitazoxanide as Bactericidal and Host-Directed Agent to Macrophages in a Mouse Model of TuberculosisAnuradha Gupta, Jairam Meena, Deepak Sharma, et al.
Tuberculosis (Edinburgh, Scotland)|April 9, 2013
Inhalable microparticles of nitric oxide donors induce phagosome maturation and kill Mycobacterium tuberculosisRahul Kumar Verma, Atul Kumar Agrawal, Amit Kumar Singh, et al.
Journal of Basic Microbiology|March 29, 2024
Insights into the genomic features and lifestyle of B1 subcluster mycobacteriophagesRitam Das, Ritu Arora, Kanika Nadar, et al.
The Journal of Physical Chemistry. B|September 22, 2015
Fluid and Resistive Tethered Lipid Membranes on Nanoporous SubstratesGautam Gupta, Kyle Staggs, Aditya D Mohite, et al.
Pageof 11